Cerenome (XMP1) Income Statement
Cerenome Income Statement
Last quarter (Q2 2026), Cerenome's total revenue was $411.00K, a decrease of 70.43% from the same quarter last year. In Q2, Cerenome's net income was $-9.01M. See Cerenome’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 5.21M | $ 5.82M | $ 4.91M | $ 224.00K | $ 0.00 | |
| $ 4.77M | $ 4.97M | $ -4.78M | $ -488.00K | $ -66.00K | |
| $ 20.07M | $ 19.67M | $ 8.54M | $ 19.22M | $ 12.43M | |
| Depreciation and Amortization | $ 445.00K | $ 872.00K | $ 628.00K | $ 619.00K | $ 395.00K |
| $ -18.33M | $ -8.38M | $ -12.29M | $ -18.95M | $ -12.07M | |
| $ -15.30M | $ -14.70M | $ -13.32M | $ -19.71M | $ -12.49M | |
| $ -7.09M | $ 1.72M | $ 5.00K | $ -563.00K | $ -907.00K | |
| $ -22.39M | $ -12.98M | $ -13.32M | $ -20.27M | $ -13.40M | |
| $ -22.39M | $ -12.98M | $ -13.32M | $ -20.27M | $ -13.40M | |
| Per Share Metrics | |||||
| Basic EPS | $ -7.19 | $ -48.75 | $ -106000.00 | $ -288750.00 | $ -444500.00 |
| Diluted EPS | $ -7.19 | $ -58.50 | $ -106000.00 | $ -288750.00 | $ -444500.00 |
| Weighted Average Shares Outstanding | 3.11M | 265.61K | 126 | 70 | 32 |
| Weighted Average Shares Outstanding (Diluted) | 3.11M | 308.03K | 126 | 70 | 32 |
Currency in USD
